Ledger.Open graph →

SEC Form D · Amendment · filed February 14, 2013

XERIS PHARMACEUTICALS INC

Offering

$3.0M

Sold

$1.8M

Exemption

—

Industry

Other

Location

AUSTIN, TX

Type

—

People & firms on this filing (12)

Steven Prestrelski · Austin, TXExec · Director Yash Sabharwal · Austin, TXExec John Kinzell · Austin, TXExec · Director Timothy Sullivan · Austin, TXDirector Shane Brisbin · Austin, TXDirector Douglas Baum · Austin, TXDirector John Mclaughlin · New York, NYExec Robert F. Kennedy · Vancouver, British Columbia, CanadaExec · Director Mary Anderson · Minneapolis, MNExec · Director Bryan Rishe · Minneapolis, MNDirector Mary Thompson · Minneapolis, MNDirector Richard Nigon · Minneapolis, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗